Sponsor Led Roundtable: Utilizing Innovative Strategies and Collaborations to Address Challenges in Neurodegenerative Trials [Clinical Studies Topic]
24 Jun 2024
Salon D
Drug Delivery
- How have advancements in science and technology transformed the landscape of degenerative neurological disease trials?
- What are the challenges and delays caused by factors like neurological biomarkers, novel therapies, FDA requirements, patient recruitment, and the inclusion of diverse age groups?
- How can we address the complexities and obstacles in today's degenerative neurology trials to keep them on track?
- What role do wearable devices play in these trials, and how can we improve their acceptance among patients?
- How can partnering with small and mid-sized CROs mitigate risks and ensure the efficacy of innovative treatments in degenerative neurology trials?